Skip to main content

Table 3 Locations and pathologic TNM stages of 33 EHPM patients

From: Prevalence and outcomes of extrahepatic primary malignancy associated with Hepatocellular Carcinoma in a Korean population

Case number EHPM site EHPM groupa pTNM stage Follow up or survival duration (months) Cause of deathb
T N M Stage
1 Rectum S 3 0 0 IIA 118  
2* Breast S 1 0 0 IA 4 H
3* Stomach S 3 3 1 IV 10 E
4* Stomach S 1 0 0 IA 21 E and O
5 Breast S 1 0 0 IA 53  
6* Kidney S 1 0 0 I 0 H
7* Rectum S 3 2 0 IIIB 12 H
8 Esophagus S 1 0 0 IA 52  
9 Kidney S 1 0 0 I 51  
10 Colon S 3 0 0 IIA 48  
11 Stomach (MALToma) S     IEA(Ann Arbor) 47  
12 Colon S 3 0 0 IIA 32  
13 Colon S 3 0 0 IIA 28  
14 Retroperitoneum S 2b 0 0 Ib 35  
15* Multiple myeloma S     III(ISS) 23 E
16 Stomach S is 0 0 0 17  
17* Rectum S 3 1 0 IIIB 4 O
18* Rectum S 4b 2b 0 IIIC 3 H and E
19* Stomach M 3 0 0 IIA 16 H
20* Kidney P NA     18 H
21 Pancreas M 3 1 0 IIIB 55  
22 Prostate M 3 0 0 III 74  
23 Breast P 2 0 0 IIA 46  
24 Colon P 2 0 0 I 27  
Stomach P 1b 0 0 IA
25 Colon M 3 0 1 IVA 38  
26 Colon M NA     24  
27 Thyroid M 3 1a 0 III 29  
28 CBD M 4 1 0 III 109  
29 Stomach P 1 0 0 IA 17  
30 Stomach P NA     0  
31* Breast P 1 0 0 IA 1 O
32 Stomach P 1 0 0 IA 20  
33 Bladder M. 1 0 0 I 100  
  1. CBD, common bile duct; EHPM, extrahepatic primary malignant neoplasm; HCC, hepatocellular carcinoma; is, in situ; NA, not applicable; pTNM stage, pathologic TNM stage.
  2. aM, metachronous group; P, prior group; S, synchronous group.
  3. bH, HCC related; E, EHPM related; O, Others.
  4. Based on AJCC 7th edition, except Ann Arbor Staging for gastric lymphoma (MALToma) and ISS (International Staging System) for multiple myeloma.
  5. *Patient who expired.